Darius Bliznikas, MD
Otolaryngology · Palos Heights, ILNPI 1235340449
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Intersect ENT, Inc. accounts for 74.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $2,501 and has fallen 98.5% since, to $38 in 2025.
Across 38 payments — averaging $103.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Aerin Medical Inc.$530
- Stryker$187
- Medtronic$88
- Smith+Nephew$82
- Paratek Pharmaceuticals, Inc.$38
- plus $84 from 4 others
What the payments were for
- Consulting fees$50013%
- Travel & lodging$1,87148%
- Food & beverage$1,55540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 18 | $2,918 |
| Aerin Medical Inc. | 3 | $530 |
| Stryker | 3 | $187 |
| Medtronic | 4 | $88 |
| Smith+Nephew | 3 | $82 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Optinose US, Inc. | 2 | $25 |
| Hikma Pharmaceuticals USA | 1 | $24 |
| Sanofi | 1 | $23 |
| Acclarent, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,926 in reported general payments places this provider in the 80th percentile of 390 otolaryngology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 146 | $3,664 |
| Fluticasone Propionate | 148 | $1,622 |
| Ofloxacin | 44 | $1,012 |
| Omeprazole | 33 | $269 |
| Doxycycline Hyclate | 28 | $269 |
| Methylprednisolone | 22 | $91 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Palos Heights
- David ConleyChicago$630K
- Jayant PintoChicago$628K
- Robert KernChicago$610K
- Robert NaclerioBurr Ridge$229K
- Michael HutzOak Park$103K
- Charles WeingartenGlenview$96K
- Victoria LeeChicago$86K
- Louis PortugalChicago$68K
- Dean ToriumiChicago$63K
- Monica PatadiaChicago$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.